Jeff Yass Susquehanna International Group
Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$4.05B |
| 2 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$1.61B |
| 3 |
Tesla
TSLA
|
+$636M |
| 4 |
TSMC
TSM
|
+$604M |
| 5 |
iShares Bitcoin Trust
IBIT
|
+$330M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$1.25B |
| 2 |
Apple
AAPL
|
+$1.13B |
| 3 |
Microsoft
MSFT
|
+$988M |
| 4 |
Meta Platforms (Facebook)
META
|
+$572M |
| 5 |
Berkshire Hathaway Class B
BRK.B
|
+$570M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 94.1% |
| 2 | Technology | 1.55% |
| 3 | Consumer Discretionary | 0.95% |
| 4 | Financials | 0.77% |
| 5 | Healthcare | 0.67% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
11651
CALL
IHS Holding
IHS
$2.82B
| $83.5K | ﹤0.01% |
16,000
+400
| +3% | +$1.53K |
|
11652
CALL
Cullinan Oncology
CGEM
$1.45B
| $83.3K | ﹤0.01% |
11,000
-8,500
| -44% | -$81.6K |
|
11653
CALL
GeoPark
GPRK
$639M
| $83.2K | ﹤0.01% |
+10,300
| New | +$92.4K |
|
|
MRSN
11654
DELISTED
Mersana Therapeutics
MRSN
| $83K | ﹤0.01% |
9,643
+7,649
| +384% | +$118K |
|
|
TEF
11655
CALL
DELISTED
Telefonica
TEF
| $82.9K | ﹤0.01% |
17,800
+3,800
| +27% | +$16.3K |
|
|
DHY
11656
Credit Suisse High Yield Credit Fund
DHY
$236M
| $82.8K | ﹤0.01% |
39,070
+7,631
| +24% | +$16.4K |
|
|
FIRY
11657
Firy Inc
FIRY
$167M
| $82.8K | ﹤0.01% |
18,403
-6,553
| -26% | -$37.4K |
|
11658
NLI Holdings
NL
$319M
| $82.2K | ﹤0.01% |
+10,410
| New | +$77.5K |
|
11659
CALL
Clean Energy Fuels
CLNE
$353M
| $82K | ﹤0.01% |
52,900
-211,800
| -80% | -$538K |
|
|
ORC
11660
CALL
Orchid Island Capital
ORC
$1.34B
| $82K | ﹤0.01% |
+10,900
| New | +$89.6K |
|
|
NXDR
11661
PUT
Nextdoor Holdings
NXDR
$897M
| $81.7K | ﹤0.01% |
+53,400
| New | +$119K |
|
11662
Caesarstone
CSTE
$111M
| $81.6K | ﹤0.01% |
33,591
+7,638
| +29% | +$28.6K |
|
11663
CALL
SkinHealth Systems
SKIN
$90M
| $81.5K | ﹤0.01% |
60,800
-11,300
| -16% | -$17.2K |
|
11664
CALL
Teucrium Wheat Fund
WEAT
$340M
| $81.4K | ﹤0.01% |
3,480
-31,740
| -90% | -$780K |
|
11665
Quest Resource Holding
QRHC
$30.4M
| $81.3K | ﹤0.01% |
31,288
+3,247
| +12% | +$15.4K |
|
11666
Purple Innovation
PRPL
$19.6M
| $81.3K | ﹤0.01% |
4,282
-16
| -0.4% | -$369 |
|
|
IAF
11667
abrdn Australia Equity Fund
IAF
$129M
| $81.1K | ﹤0.01% |
+6,710
| New | +$85.6K |
|
|
DENN
11668
CALL
DELISTED
Denny's
DENN
| $81.1K | ﹤0.01% |
22,100
+4,500
| +26% | +$23.7K |
|
11669
Austin Gold Corp
AUST
$17.1M
| $80.8K | ﹤0.01% |
+62,165
| New | +$83.1K |
|
11670
PUT
Cabaletta Bio
CABA
$573M
| $80.6K | ﹤0.01% |
58,000
+27,400
| +90% | +$58.4K |
|
11671
CALL
iHeartMedia
IHRT
$416M
| $80.5K | ﹤0.01% |
48,800
-36,900
| -43% | -$74.3K |
|
|
CMCM
11672
CALL
Cheetah Mobile
CMCM
$92.8M
| $80.3K | ﹤0.01% |
+18,800
| New | +$92.9K |
|
|
DAWN
11673
CALL
DELISTED
Day One Biopharmaceuticals
DAWN
| $80.1K | ﹤0.01% |
10,100
-10,300
| -50% | -$111K |
|
|
11674
Cabaletta Bio
CABA
$573M
| $80K | ﹤0.01% |
57,780
-374,155
| -87% | -$797K |
|
11675
CALL
MiMedx Group
MDXG
$657M
| $79.8K | ﹤0.01% |
10,500
-17,700
| -63% | -$148K |
|
Similar funds
Jeff Yass's Q1 2025 Portfolio in Review
As of Q1 2025, Jeff Yass held 13,842 positions worth $586B, down 12% from $663B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Jeff Yass's Q1 2025 filing shows 1,775 new, 5,712 increased, 4,842 reduced and 1,482 closed positions. Its largest new stake was Brookfield Asset Management: 1,775,684 shares worth $86M. The largest sale was Invesco QQQ Trust, an estimated $1.25B.
By sector, the portfolio is most concentrated in Miscellaneous at 94% of assets, up from 93% a quarter earlier, followed by Technology and Consumer Discretionary.
- Jeff Yass's largest Q1 2025 buy was Brookfield Asset Management: 1,775,684 shares worth $86M.
- Jeff Yass added most to State Street SPDR S&P 500 ETF Trust in Q1 2025, an estimated $4.05B increase.
- Jeff Yass's biggest Q1 2025 reduction was Invesco QQQ Trust, cutting an estimated $1.25B.
- Jeff Yass fully exited Inari Medical, Inc. Common Stock in Q1 2025, selling an estimated $24M.
- Jeff Yass's ten largest holdings make up 28% of its $586B portfolio in Q1 2025.
- Jeff Yass opened 1,775 new positions and closed 1,482 in Q1 2025.
- Jeff Yass's portfolio value fell 12% quarter-over-quarter to $586B.
Based on Susquehanna International Group's 13F filing for Q1 2025, filed 14 May 2025.